LexDanaLexDanabeta
Inventor

David J. Cavalla

Inventor
Cambridge, GB

Overview

43→
Patents
1989–2017
Patent span
Chemistry
Primary field (CPC C)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds48%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations41%
A61KPreparations for medical, dental or toiletry purposes7%
C07CAcyclic or carbocyclic compounds4%
PatentTitleYear
9,610,291'Treatment of respiratory depression'20179,487,492'Dibenzothiazepine derivatives and their use in the treatment of CNS disorders'20168,716,325'Treatment of cachexia'20147,470,690'4-(2-Fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D)pyrimidine in the treatment of functional bowel disorder'20087,220,748'Use of 4-(2-Flurophenyl)-6-methyl-2-(1-piperazinyl)thieno(2,3-D)-pyrimidine for treating of urinary incontinence'20076,440,979'Aryl isoguanines'20026,413,975'Purine derivatives having phosphodiesterase iv inhibition activity'20026,372,770'Benzoxazoles'20026,365,606'6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity'20026,319,928'Purine derivatives having phosphodiesterase IV inhibition activity'20016,310,205'Hypoxathine compounds'20016,294,541'Purine derivatives having phosphodiesterase IV inhibition activity'20016,268,373'Trisubstituted thioxanthines'20016,248,746'3-(arylalkyl) xanthines'20016,248,769'Phenyl-triazole compounds for PDE-IV inhibition'20016,228,859'Purine derivatives having phosphodiesterase IV inhibition activity'20016,211,367'Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity'20016,166,041'2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma'20006,153,630'Phenylpyridyl compounds for inhibiting phosphodiesterase IV and methods of using same'20006,103,749'Aryl imidazole compounds having phosphodiesterase IV inhibitory activity'20006,090,816'Aryl thioxanthines'20006,075,016'6,5-fused aromatic ring systems having enhanced phosphodiesterase IV inhibitory activity'20006,066,641'Aryl thioxanthines'20006,057,445'Purine compounds having PDE IV inhibitory activity and methods of synthesis'20006,040,447'Purine compounds having PDE IV inhibitory activity and methods of synthesis'20006,037,470'Purine compounds having PDE IV inhibitory activity and methods of synthesis'20006,025,361'Trisubstituted thioxanthines'20005,977,119'Trisubstituted thioxanthines'19995,939,422'Chemical compounds having PDE-IV inhibition activity'19995,922,751'Aryl pyrazole compound for inhibiting phosphodiesterase IV and methods of using same'19995,889,014'Heterocyclic compounds for inhibiting phosphodiesterase IV'19995,864,037'Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity'19995,744,473'PDE IV inhibitors: \"bis-compounds\"'19985,591,776'Pheynl or benzyl-substituted rolipram-based compounds for and method of inhibiting phosphodiesterase IV'19975,114,950'5,6-dihydro-N-[(imidazol-4(or 5)-yl)methyl]-4H-pyrrolo[3,2,1-IJ]quinoline-1-carboxamides having 5-HT.sub. antagonist activity'19925,084,474'Ketone derivatives'19925,026,696'Ketone derivatives which are antagonists of 5-HT at 5-HT.sub.3 receptors, compositions containing them, and method of use'19915,026,722'Indole derivatives'19915,006,544'Imidazole derivatives and pharmaceutical use thereof'19914,963,546'Ketone derivatives which are antagonists of 5-HT at 5-HT.sub.3 receptors, compositions containing them, and method of use'19904,950,681'Ketone derivatives'19904,918,080'Imidazollyl containing ketone derivatives'19904,808,581'Imidazolyl- indolylpropanones as 5-HT.sub.3 receptor antagonists'1989

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1989–1992Patents assigned to GLAXO GROUP LTD (9)· patent assignee history
1989–1992Based in London, GB· patent location history
1991–2016Based in Cambridge, GB· patent location history
1997–2002Patents assigned to EURO CELTIQUE SA (29)· patent assignee history
2007Patents assigned to ARACHNOVA THERAPEUTICS LTD (1)· patent assignee history
2014–2016Patents assigned to CAVALLA DAVID (2)· patent assignee history
2016–2017Patents assigned to NUMEDICUS LTD (2)· patent assignee history
2017Based in Cambridgeshire, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
EURO CELTIQUE SA291997–2002
GLAXO GROUP LTD91989–1992
CAVALLA DAVIDself22014–2016
NUMEDICUS LTD22016–2017
ARACHNOVA THERAPEUTICS LTD12007
Locations
LocationPatentsSpan
Cambridge, GB361991–2016
London, GB61989–1992
Cambridgeshire, GB12017